111 related articles for article (PubMed ID: 11031792)
1. [TIPS: value in the treatment of therapy refractory ascites].
Staritz M; Jaeger O; Matschke H; Riesterer H; Sauer B
Z Gastroenterol; 2000 Aug; 38(8):655-6. PubMed ID: 11031792
[No Abstract] [Full Text] [Related]
2. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
Aalykke C; Tønner-Nielsen D; Vilstrup H
Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
[No Abstract] [Full Text] [Related]
3. TIPS versus paracentesis for the treatment of refractory ascites.
Lau A; Bay C; Nadir A
Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
[No Abstract] [Full Text] [Related]
4. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
5. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
6. [TIPS or paracentesis in refractory ascites?].
Poralla T
Z Gastroenterol; 1997 Dec; 35(12):1115-8. PubMed ID: 9487644
[No Abstract] [Full Text] [Related]
7. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
9. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
10. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
11. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
12. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
[TBL] [Abstract][Full Text] [Related]
13. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
14. TIPS in refractory ascites in cirrhosis: not only survival is the clue.
Ockenga J; Schuetz T; Lochs H
Gastroenterology; 2003 Sep; 125(3):997-8. PubMed ID: 12974267
[No Abstract] [Full Text] [Related]
15. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Uriz J; Cárdenas A; Arroyo V
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
[TBL] [Abstract][Full Text] [Related]
16. Pros and cons of TIPS for refractory ascites.
Sanyal AJ
J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
[No Abstract] [Full Text] [Related]
17. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
Albillos A; Bañares R; González M; Catalina MV; Molinero LM
J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
[TBL] [Abstract][Full Text] [Related]
20. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
